Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Technique
- Analyzed With
- Chemical Group
- Compounds
- Detection Technique
- Injection Technique
- Instrument
- Analysis Platform
- Language
- Publication Date
1 - 20 of 24 results
Applied Filters
必威体育登录手机In this application note, we show that method transfer can be easy and convenient with the new Agilent 1290 Infinity II Bio LC System.
必威体育登录手机This application note demonstrates the reliable separation of 2-AB- and InstantPC-labeled glycans with the Agilent 1290 Infinity II Bio LC System under resolution- and speed-optimized conditions.
必威体育登录手机In this application note, we developed LC methods for oligonucleotide raw material analysis based on the biocompatible Agilent 1290 Infinity II Bio LC.
必威体育登录手机This application note demonstrates the drug-to-antibody (DAR) determination of brentuximab vedotin using a ternary gradient with the Agilent Infinity II Prime Bio LC.
必威体育登录手机This application note demonstrates the superior resolution in size exclusion chromatography (SEC) protein separation made possible by the Agilent 1290 Infinity II Bio LC System equipped with the Agilent AdvanceBio SEC column and ultralow dispersion...
This application note demonstrates the DAR determination of brentuximab vedotin using HIC.
必威体育登录手机In this application note, we present the new Agilent 1290 Infinity II Bio LC as the system of choice for peptide mapping.
必威体育登录手机The evaluation of different salt gradients was performed on the Agilent 1290 Infinity II Bio LC System and analyzed for resolution as well as reproducibility.
Critical Quality Attribute Monitoring of mAbs at the Intact and Subunit Levels
必威体育登录手机Presents a method for protein analysis using an Agilent LC/MSD XT and 1260 Infinity II LC.
必威体育登录手机Presents a method for peptide mapping using an Agilent LC/MSD XT and 1290 Infinity II LC.
必威体育登录手机Determination of drug to antibody ratio of brentuximab vedotin using hydrophobic interaction chromatography on the Agilent 1260 Infinity II Bio-inert LC
Demonstion of the use of multiple heart-cutting two-dimensional liquid chromatography for automated desalting of glucagon from an MS incompatible USP method.
Identification of monoclonal antibody mutation sites using the 1290 Infinity II 2D-LC solution with 6530 Q-TOF LC/MS.
必威体育登录手机This application note evaluates the performance of an Agilent LC/MS in terms of achievable mass accuracy and spectral accuracy to enable unknown formula ID.
必威体育登录手机The Agilent InfinityLab Bio-inert LC Solution is a complete, 100 percent bio-inert solution designed for unmatched confidence in your biomolecule analysis.
Application Note showing the analysis of N-linked glycans with hydrophilic interaction chromatography (HILIC) separation
必威体育登录手机Small –scale purification of a monoclonal antibody from a cell lysate and the subsequent analysis on a single instrument, the Agilent 1260 Infinity Bio-inert Quaternary LC.
| Publication Part Number | 5991-1195EN | ||||
|---|---|---|---|---|---|
| Analysis | Analysed with Part No. |
|
|||
| Instrument |
|
||||
| Analytical Technique | Technique |
|
|||
| Injection |
|
||||
| Detection |
|
||||
| Sample | Chemical Group |
|
|||
| 示例矩陣 |
|
必威体育登录手机The Agilent 1260 Infinity Bio-inert Quaternary LC with fluorescence detection and Agilent Bio SAX analyzed N-linked glycans with.excellent resolution and precision.